cannabis news

Cannabis stocks are experiencing notable declines this Thursday, aligning with a general downturn across major economic indices. At the time of publication of this article, the S&P 500 index was trading down by 1.62%, the Nasdaq 100 by 2.44%, and the Dow Jones Industrial Average (DJIA) showed a...

The hemp industry is advancing in Costa Rica. Between November 8, 2022 and September 3, 2024, the Ministry of Agriculture and Livestock (MAG) issued 57 licenses for hemp cultivation and derivative production. Each license is valid for six years. According to MAG data, these hemp licenses are...

This week, Kentucky and Delaware held crucial licensing lotteries as part of their state cannabis programs, each paving a new path for regulated medical and recreational cannabis markets. On October 29, Kentucky awarded its first 26 medical cannabis licenses through a lottery organized by the...

New York Attorney General Letitia James announced a $9.5 million judgment against George West, the owner of an unlicensed cannabis dispensary in Ontario County. This sentence followed his refusal to comply with a June 2023 order from the Office of Cannabis Management (OCM) to cease operations. West...

Two federally funded studies published in the Journal of the American Medical Association (JAMA) provide critical insights into the effects of prenatal cannabis use on child development. Led by Lyndsay A. Avalos, PhD, MPH, the studies conclude that early maternal cannabis use is not associated with...

As Florida gears up for a monumental vote in November 2024, Amendment 3, which would legalize recreational cannabis use, is gaining significant support from key voices. One who has just joined the chorus is Gordon Smith, the Sheriff of Bradford County, a region in North Central Florida with a...

Washington State University (WSU) researchers have received a $670,000 grant from the National Institutes of Health (NIH) to tackle cannabis misuse among young adults. The project, led by Stacey Hust and Jessica Willoughby, will focus on educating college students in three states where cannabis is...

Cannabis legalization continues to gain momentum across the U.S., with states like Minnesota, Delaware and Ohio embracing recreational in 2023 and 2024, while Florida prepares to vote on a similar measure in November. Despite widespread public support and state-level reforms, the Senate remains a...

Sacramento is exploring the possibility of allowing on-site cannabis consumption at dispensaries through a new pilot program. If approved, this pilot program would introduce consumption lounges, giving residents a safe and social space to enjoy cannabis legally in the capital city of California....

Zuanic & Associates hosted an online panel, “The Hemp Derivatives Advocates” that brought together key players in the hemp industry to discuss the regulatory challenges around hemp-derived products. In the midst of this national discussion, Christopher Lackner, president of the Hemp...

Cannatrol, a company specializing in post-harvest cannabis processing, partnered with the Cannabis Research Coalition (CRC) to to explore the impact of vapor pressure stability on cannabis quality. Research findings reveal how advanced post-harvest drying methods impact cannabis flower quality,...

Investment manager fund Chicago Atlantic recently acquired Silver Spike Investment Corp. (NASDAD: SSIC), the only SEC-approved business development company (BDC) focused on lending to the cannabis industry. As a result, Silver Spike has been renamed Chicago Atlantic BDC, Inc., and its ticker symbol...

Several cannabis companies faced financial challenges in 2024, with some being delisted or under threat of delisting from major stock exchanges due to financial instability, low values, compliance issues and a turbulent market. This article looks into some of the key players that faced delisting,...

Allegations of predatory contracts within Missouri's social equity cannabis program have surfaced, raising concerns about the integrity of the system. A recent investigation by The Missouri Independent revealed a troubling case involving Destiny Brown, a Black woman who believed she was being...

Shares of Corbus Pharmaceuticals (NASDAQ:CRBP) experienced a severe drop on Friday, plummeting almost 60% from $52 to $21, as competitor Novo Nordisk (NYSE:NVO) published trial results for monlunabant, a cannabinoid receptor 1 (CB1) inverse agonist. Novo Nordisk shares also traded down roughly 5.5...